These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 6383845

  • 1. Differences in kidney renin content between normotensive and spontaneously hypertensive rats: effect of captopril treatment.
    Antonaccio MJ, Harris D, Goldenberg H.
    Eur J Pharmacol; 1984 Aug 03; 103(1-2):157-9. PubMed ID: 6383845
    [Abstract] [Full Text] [Related]

  • 2. Kidney renin gene expression in spontaneously hypertensive rats.
    Kitami Y, Hiwada K, Kokubu T.
    J Hypertens; 1989 Sep 03; 7(9):727-31. PubMed ID: 2677137
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin-converting enzyme blockade by Captopril changes angiotensin II receptors and angiotensinogen concentrations in the brain of SHR-sp and WKY rats.
    Felix D, Schelling P.
    Neurosci Lett; 1982 Dec 23; 34(1):45-50. PubMed ID: 6298670
    [Abstract] [Full Text] [Related]

  • 4. Influence of captopril treatment on angiotensin II receptors and angiotensinogen in the brain of spontaneously hypertensive rats.
    Schelling P, Felix D.
    Hypertension; 1983 Dec 23; 5(6):935-42. PubMed ID: 6317552
    [Abstract] [Full Text] [Related]

  • 5. Hypotensive action of captopril in spontaneously hypertensive and normotensive rats. Interference with neurogenic vasoconstriction.
    Clough DP, Hatton R, Keddie JR, Collis MG.
    Hypertension; 1982 Dec 23; 4(6):764-72. PubMed ID: 6292083
    [Abstract] [Full Text] [Related]

  • 6. Vascular wall renin in spontaneously hypertensive rats. Potential relevance to hypertension maintenance and antihypertensive effect of captopril.
    Asaad MM, Antonaccio MJ.
    Hypertension; 1982 Dec 23; 4(4):487-93. PubMed ID: 6759392
    [Abstract] [Full Text] [Related]

  • 7. [Significance of brain renin for pathogenesis of hypertension: effect of antihypertensive drugs on active and inactive renins in the brain of spontaneously hypertensive rat].
    Watari H.
    Nihon Naibunpi Gakkai Zasshi; 1989 Jan 20; 65(1):66-78. PubMed ID: 2656313
    [Abstract] [Full Text] [Related]

  • 8. Effects of captopril on the renin angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats.
    Bolterman RJ, Manriquez MC, Ortiz Ruiz MC, Juncos LA, Romero JC.
    Hypertension; 2005 Oct 20; 46(4):943-7. PubMed ID: 16087785
    [Abstract] [Full Text] [Related]

  • 9. Immunohistochemical findings of juxtaglomerular cells on acute phase in two-kidney Goldblatt hypertensive rats and spontaneously hypertensive rats.
    Yamakoshi J, Ohshita K, Takahashi R.
    J Vet Med Sci; 1992 Oct 20; 54(5):857-63. PubMed ID: 1420565
    [Abstract] [Full Text] [Related]

  • 10. Blood pressure responses of conscious normotensive and spontaneously hypertensive rats to intracerebroventricular and peripheral administration of captopril.
    Hutchinson JS, Mendelsohn FA, Doyle AE.
    Hypertension; 1980 Oct 20; 2(4):546-50. PubMed ID: 6995295
    [Abstract] [Full Text] [Related]

  • 11. Involvement of complement 3 in the salt-sensitive hypertension by activation of renal renin-angiotensin system in spontaneously hypertensive rats.
    Negishi E, Fukuda N, Otsuki T, Katakawa M, Komatsu K, Chen L, Tanaka S, Kobayashi H, Hatanaka Y, Ueno T, Endo M, Mashimo T, Nishiyama A, Abe M.
    Am J Physiol Renal Physiol; 2018 Dec 01; 315(6):F1747-F1758. PubMed ID: 30256128
    [Abstract] [Full Text] [Related]

  • 12. Effects of captopril on vascular noradrenergic transmission in SHR.
    Eikenburg DC.
    Hypertension; 1984 Dec 01; 6(5):660-5. PubMed ID: 6094342
    [Abstract] [Full Text] [Related]

  • 13. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats.
    De Godoy MA, Rattan S.
    J Pharmacol Exp Ther; 2006 Aug 01; 318(2):725-34. PubMed ID: 16648368
    [Abstract] [Full Text] [Related]

  • 14. Involvement of the vascular renin-angiotensin system in beta adrenergic receptor-mediated facilitation of vascular neurotransmission in spontaneously hypertensive rats.
    Kawasaki H, Cline WH, Su C.
    J Pharmacol Exp Ther; 1984 Oct 01; 231(1):23-32. PubMed ID: 6149303
    [Abstract] [Full Text] [Related]

  • 15. Brain renin angiotensin system contributes to the salt-induced enhancement of hypertension in SHR.
    Takata Y, Yamashita Y, Takishita S, Kimura Y, Fujishima M.
    Clin Exp Hypertens A; 1986 Oct 01; 8(7):1149-70. PubMed ID: 2876791
    [Abstract] [Full Text] [Related]

  • 16. Captopril modifies gene expression in hypertrophied and failing hearts of aged spontaneously hypertensive rats.
    Brooks WW, Bing OH, Conrad CH, O'Neill L, Crow MT, Lakatta EG, Dostal DE, Baker KM, Boluyt MO.
    Hypertension; 1997 Dec 01; 30(6):1362-8. PubMed ID: 9403554
    [Abstract] [Full Text] [Related]

  • 17. Captopril avoids hypertension, the increase in plasma angiotensin II but increases angiotensin 1-7 and angiotensin II-induced perfusion pressure in isolated kidney in SHR.
    Castro-Moreno P, Pardo JP, Hernández-Muñoz R, López-Guerrero JJ, Del Valle-Mondragón L, Pastelín-Hernández G, Ibarra-Barajas M, Villalobos-Molina R.
    Auton Autacoid Pharmacol; 2012 Oct 01; 32(3 Pt 4):61-9. PubMed ID: 22994939
    [Abstract] [Full Text] [Related]

  • 18. Enhanced slow-pressor response to angiotensin II in spontaneously hypertensive rats.
    Li P, Jackson EK.
    J Pharmacol Exp Ther; 1989 Dec 01; 251(3):909-21. PubMed ID: 2557422
    [Abstract] [Full Text] [Related]

  • 19. Effect of captopril on intracellular free calcium ([Ca2+]i) of thymocytes in spontaneously hypertensive rats.
    Xie L, Chen D, Wu D, Wang H.
    J Hum Hypertens; 1996 Jun 01; 10(6):425-7. PubMed ID: 8872812
    [Abstract] [Full Text] [Related]

  • 20. Low-dose angiotensin II reduces urinary cyclic AMP excretion in spontaneously hypertensive, but not normotensive, rats: independence from hypertension and renal hemodynamic effects of angiotensin.
    Jackson EK, Herzer WA, Mi Z, Vyas SJ, Kost CK.
    J Pharmacol Exp Ther; 1999 Oct 01; 291(1):115-23. PubMed ID: 10490894
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.